{"id":"https://openalex.org/W2140799285","doi":"https://doi.org/10.1126/science.281.5383.1640","title":"Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors","display_name":"Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors","publication_year":1998,"publication_date":"1998-09-11","ids":{"openalex":"https://openalex.org/W2140799285","doi":"https://doi.org/10.1126/science.281.5383.1640","mag":"2140799285","pmid":"https://pubmed.ncbi.nlm.nih.gov/9733503"},"language":"en","primary_location":{"id":"doi:10.1126/science.281.5383.1640","doi":"https://doi.org/10.1126/science.281.5383.1640","is_oa":false,"landing_page_url":"https://doi.org/10.1126/science.281.5383.1640","pdf_url":null,"source":{"id":"https://openalex.org/S3880285","display_name":"Science","issn_l":"0036-8075","issn":["0036-8075","0193-4511","1095-9203"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070746400","display_name":"Mark S. Kramer","orcid":"https://orcid.org/0000-0001-9272-8266","observed_orcids":["https://orcid.org/0000-0001-9272-8266"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mark S. Kramer","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070455767","display_name":"Neal R. Cutler","orcid":"https://orcid.org/0000-0002-0639-2266","observed_orcids":["https://orcid.org/0000-0002-0639-2266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neal Cutler","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112066093","display_name":"John P. Feighner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Feighner","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011246174","display_name":"Ram K. Shrivastava","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ram Shrivastava","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025639497","display_name":"John Scott Carman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Carman","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084201235","display_name":"John J. Sramek","orcid":"https://orcid.org/0000-0002-0762-0240","observed_orcids":["https://orcid.org/0000-0002-0762-0240"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John J. Sramek","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108500608","display_name":"Scott A. Reines","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott A. Reines","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039583103","display_name":"Guanghan Frank Liu","orcid":"https://orcid.org/0000-0001-7817-7656","observed_orcids":["https://orcid.org/0000-0001-7817-7656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guanghan Liu","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108490199","display_name":"Duane B Snavely","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Duane Snavely","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057577544","display_name":"Edwina S. Wyatt-Knowles","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edwina Wyatt-Knowles","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026055012","display_name":"Jeffrey J. Hale","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey J. Hale","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065104076","display_name":"Sander G. Mills","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sander G. Mills","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072320748","display_name":"Malcolm MacCoss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malcolm MacCoss","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071409001","display_name":"Christopher J. Swain","orcid":"https://orcid.org/0000-0002-9422-3525","observed_orcids":["https://orcid.org/0000-0002-9422-3525"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher J. Swain","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041179742","display_name":"Timothy Harrison","orcid":"https://orcid.org/0000-0001-8782-6697","observed_orcids":["https://orcid.org/0000-0001-8782-6697"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy Harrison","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103487003","display_name":"R.G. Hill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raymond G. Hill","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054270816","display_name":"Franz F. Hefti","orcid":"https://orcid.org/0000-0002-1177-2714","observed_orcids":["https://orcid.org/0000-0002-1177-2714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Franz Hefti","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053626123","display_name":"Edward M. Scolnick","orcid":"https://orcid.org/0000-0001-9429-1547","observed_orcids":["https://orcid.org/0000-0001-9429-1547"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward M. Scolnick","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108215906","display_name":"Margaret A. Cascieri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret A. Cascieri","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056488783","display_name":"Gary G. Chicchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary G. Chicchi","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016511114","display_name":"Sharon J. Sadowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Sadowski","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052402905","display_name":"Angela R. Williams","orcid":"https://orcid.org/0000-0001-6808-8983","observed_orcids":["https://orcid.org/0000-0001-6808-8983"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela R. Williams","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002877660","display_name":"Louise Hewson","orcid":"https://orcid.org/0000-0001-6630-7089","observed_orcids":["https://orcid.org/0000-0001-6630-7089"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Louise Hewson","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Smith","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109970325","display_name":"Emma J. Carlson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emma J. Carlson","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110221578","display_name":"Richard J Hargreaves","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard J. Hargreaves","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069068117","display_name":"Nadia M.J. Rupniak","orcid":"https://orcid.org/0000-0003-2314-1108","observed_orcids":["https://orcid.org/0000-0003-2314-1108"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Nadia M. J. Rupniak","raw_affiliation_strings":["M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. Kramer and N. Rupniak are the principal contributors to the clinical and preclinical studies, respectively","institution_ids":[]},{"raw_affiliation_string":"M. S. Kramer is at Merck Research Laboratories, West Point, PA 19456, USA, and in the Department of Psychiatry and Human Behavior, Thomas Jefferson Medical College, Philadelphia, PA 19107, USA. N. Cutler and J. J. Sramek are at California Clinical Trials, Beverly Hills, CA 90211, USA. J. Feighner is at the Feighner Research Institute, San Diego, CA 92121, USA. R. Shrivastava is at the Eastside Medical Group, New York, NY 10021, USA. J. Carman is at Carman Research, Smyrna, GA 30080, USA. S. A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5069068117","https://openalex.org/A5070746400"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":46.1488,"has_fulltext":false,"cited_by_count":1061,"citation_normalized_percentile":{"value":0.99929677,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"281","issue":"5383","first_page":"1640","last_page":"1645"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.33500000834465027,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.03420000150799751,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/substance-p","display_name":"substance P","score":0.8500000238418579},{"id":"https://openalex.org/keywords/substance-p-receptor-antagonist","display_name":"substance P antagonist","score":0.8050000071525574},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.7039999961853027},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8080000281333923},{"id":"https://openalex.org/keywords/stress-response","display_name":"stress response","score":0.7789999842643738},{"id":"https://openalex.org/keywords/monoaminergic-systems","display_name":"monoaminergic systems","score":0.7910000085830688},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.7480000257492065},{"id":"https://openalex.org/keywords/mental-disorders","display_name":"mental illness","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C42251903","wikidata":"https://www.wikidata.org/wiki/Q18391002","display_name":"Monoaminergic","level":4,"score":0.7792593240737915},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.7718530893325806},{"id":"https://openalex.org/C2776533618","wikidata":"https://www.wikidata.org/wiki/Q411041","display_name":"Substance P","level":4,"score":0.7681452035903931},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.5733532309532166},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.5620750784873962},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5145020484924316},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47136202454566956},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.45144128799438477},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4218358099460602},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40994542837142944},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4029141962528229},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.35204991698265076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32858771085739136},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3112473487854004},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2409897744655609},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.2396242916584015},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.10840123891830444},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077608","descriptor_name":"Aprepitant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000679","descriptor_name":"Amygdala","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000679","descriptor_name":"Amygdala","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005849","descriptor_name":"Gerbillinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D013315","descriptor_name":"Stress, Psychological","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013373","descriptor_name":"Substance P","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013373","descriptor_name":"Substance P","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014828","descriptor_name":"Vocalization, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018040","descriptor_name":"Receptors, Neurokinin-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D064729","descriptor_name":"Neurokinin-1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1126/science.281.5383.1640","doi":"https://doi.org/10.1126/science.281.5383.1640","is_oa":false,"landing_page_url":"https://doi.org/10.1126/science.281.5383.1640","pdf_url":null,"source":{"id":"https://openalex.org/S3880285","display_name":"Science","issn_l":"0036-8075","issn":["0036-8075","0193-4511","1095-9203"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science","raw_type":"journal-article"},{"id":"pmid:9733503","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9733503","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science (New York, N.Y.)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W253326700","https://openalex.org/W1573840829","https://openalex.org/W1660439970","https://openalex.org/W1872987381","https://openalex.org/W1963931614","https://openalex.org/W1968598878","https://openalex.org/W1970344711","https://openalex.org/W1970954584","https://openalex.org/W1973167593","https://openalex.org/W1973871311","https://openalex.org/W1974573132","https://openalex.org/W1975592075","https://openalex.org/W1976644902","https://openalex.org/W1977475600","https://openalex.org/W1978378330","https://openalex.org/W1980260788","https://openalex.org/W1982585253","https://openalex.org/W1987674919","https://openalex.org/W1991593059","https://openalex.org/W1994590985","https://openalex.org/W1996980482","https://openalex.org/W2001937753","https://openalex.org/W2003847276","https://openalex.org/W2004251390","https://openalex.org/W2004353058","https://openalex.org/W2005733450","https://openalex.org/W2008623166","https://openalex.org/W2012434214","https://openalex.org/W2013736669","https://openalex.org/W2016118895","https://openalex.org/W2021647365","https://openalex.org/W2023800668","https://openalex.org/W2031706219","https://openalex.org/W2031977325","https://openalex.org/W2047332611","https://openalex.org/W2050867100","https://openalex.org/W2051642224","https://openalex.org/W2060172635","https://openalex.org/W2060937867","https://openalex.org/W2065864851","https://openalex.org/W2069315606","https://openalex.org/W2073233024","https://openalex.org/W2085857996","https://openalex.org/W2094303015","https://openalex.org/W2094507548","https://openalex.org/W2112322278","https://openalex.org/W2119505982","https://openalex.org/W2142514218","https://openalex.org/W2160874664","https://openalex.org/W2209176793","https://openalex.org/W2335791359","https://openalex.org/W2411927542","https://openalex.org/W2460521578","https://openalex.org/W6609482113"],"related_works":["https://openalex.org/W2166892357","https://openalex.org/W2413370990","https://openalex.org/W2052497672","https://openalex.org/W1989708799","https://openalex.org/W2413155058","https://openalex.org/W2417516434","https://openalex.org/W2052921584","https://openalex.org/W4323284214","https://openalex.org/W2001989148","https://openalex.org/W2023258549"],"abstract_inverted_index":{"The":[0],"localization":[1],"of":[2,57],"substance":[3,19,33,59,69,90],"P":[4,20,34,60,70,91],"in":[5,39,46,78,97],"brain":[6],"regions":[7],"that":[8,18,89],"coordinate":[9],"stress":[10],"responses":[11],"and":[12,30],"receive":[13],"convergent":[14],"monoaminergic":[15],"innervation":[16],"suggested":[17],"antagonists":[21,35,71],"might":[22],"have":[23],"psychotherapeutic":[24],"properties.":[25],"Like":[26],"clinically":[27],"used":[28],"antidepressant":[29,55,84],"anxiolytic":[31],"drugs,":[32],"suppressed":[36],"isolation-induced":[37],"vocalizations":[38],"guinea":[40],"pigs.":[41],"In":[42,66],"a":[43],"placebo-controlled":[44],"trial":[45],"patients":[47],"with":[48,75,82],"moderate":[49],"to":[50],"severe":[51],"major":[52],"depression,":[53],"robust":[54],"effects":[56],"the":[58,79],"antagonist":[61],"MK-869":[62],"were":[63],"consistently":[64],"observed.":[65],"preclinical":[67],"studies,":[68],"did":[72],"not":[73],"interact":[74],"monoamine":[76],"systems":[77],"manner":[80],"seen":[81],"established":[83],"drugs.":[85],"These":[86],"findings":[87],"suggest":[88],"may":[92],"play":[93],"an":[94],"important":[95],"role":[96],"psychiatric":[98],"disorders.":[99]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":22},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":28},{"year":2013,"cited_by_count":34},{"year":2012,"cited_by_count":33}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}